FPR1 and obesity disorder: While the expression of Fpr1 and Fpr2 in the hypothalamus is lower compared to other tissues (data not shown), it will be necessary to investigate the potential pathway of obesity reduction through inhibiting the inflammatory response in the hypothalamus, as WKYMVm demonstrates anti‐inflammatory characteristics.